News Related to Prostate Cancer
-
PSA Screening Controversy: FAQ
May 24, 2012 -- Don't get the PSA prostate-cancer screening test, a U.S. expert panel says. Do get it, many urologists and patient advocates say. What's a man supposed to do? To provide clarity amid the controversy, here's WebMD's FAQ. PSA is prostate specific antigen. It's a molecule specific to th
Read Full Article -
Some Cholesterol Drugs May Slow Prostate Growth
May 21, 2012 -- Cholesterol-lowering statins may also slow the growth of the prostate, according to researchers at Duke University. Their findings could eventually lead to new treatments for the millions of middle-aged and older men who experience urinary and other problems as a result of benign, ag
Read Full Article -
Panel: Don't Get PSA Prostate Cancer Screen
May 21, 2012 -- Men should not get routine PSA tests to screen for prostate cancer, the U.S. Preventive Services Task Force today reaffirmed. The USPSTF is the independent panel that sets U.S. cancer-screening policy. Last October, the group released a draft report finding that men get far more harm
Read Full Article -
Best Prostate Cancer Radiation?
April 16, 2012 -- The most popular form of radiation therapy for prostate cancer may also be the best, a new comparison study finds. Nearly all men with prostate cancer who opt for external beam radiation get a treatment called intensity-modulated radiation therapy or IMRT. IMRT has almost entirely
Read Full Article -
Ultrasound 'Male Lumpectomy' for Prostate Cancer
April 17, 2012 -- An experimental treatment zaps prostate tumors while leaving healthy prostate tissue intact. It's been called "male lumpectomy," because like less-invasive forms of breast cancer surgery, it removes tumors without removing the entire organ affected by cancer. The treatment, under d
Read Full Article -
Common Diabetes Drug May Fight Cancer
April 3, 2012 (Chicago) -- The diabetes drug metformin -- commonly a first choice for controlling blood sugar in people with type 2 diabetes -- is sparking new interest as a cancer fighter. A new study presented here at the American Association for Cancer Research (AACR) annual meeting shows that me
Read Full Article -
PSA Test Cuts Prostate Cancer Deaths -- at a Cost
March 14, 2012 -- The odds of dying from prostate cancer are 21% lower 11 years after men are offered routine screening with the controversial PSA blood test, European researchers find. Those odds go down 29% if you only count men who actually got screened in the huge European Randomized Study of Sc
Read Full Article -
Study: Radioactive Seeds Beat Out Other Prostate Cancer Treatments
Jan. 31, 2012 -- For most men with prostate cancer, having radioactive seeds implanted in the prostate is associated with fewer serious side effects than either surgery to remove the prostate or having a beam of high-energy radiation aimed directly at the cancer, researchers say. The analysis of the
Read Full Article -
New Type of Prostate Cancer Pill Extends Lives
Jan. 31, 2012 -- An experimental pill that works differently than other prostate cancer drugs extended the lives of men with spreading cancer by an average of nearly five months. Men with late-stage prostate cancer given the new hormone treatment, MDV3100, lived an average of nearly a year-and-a-hal
Read Full Article -
Drug for Enlarged Prostate May Slow Cancer Growth
Jan. 23, 2012 -- A drug widely prescribed to treat men with enlarged prostates may also slow the growth of early prostate cancers, according to a new study. Researchers say the drug Avodart (dutasteride) may reduce the need for aggressive treatments in men who have a very low risk of dying from thei
Read Full Article

